台股 » 個股 » 旭富 » 籌碼相關 » 融資融券與借券

旭富

(4119)
可現股當沖
  • 股價
    90.6
  • 漲跌
    ▼1.9
  • 漲幅
    -2.05%
  • 成交量
    371
  • 產業
    上市 生技醫療類股
  • 352人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

旭富 (4119) 融資融券與借券

旭富 (4119) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
12/1341,7075.71-150.02000.2990.6-2.05%371
12/12-151,7035.7060.02000.3592.5-1.60%281
12/111291,7185.75-160.02000.35940.00%262
12/10171,5895.32170.02000.44940.64%193
12/09-21,5725.26-160.02000.3893.4-3.71%506
12/06-91,5745.27070.02000.4497-0.41%138
12/05-201,5835.3070.02000.4497.4-0.41%251
12/04-281,6035.37070.02000.4497.80.00%246
12/03-331,6315.46070.02000.4397.81.77%803
12/02-91,6645.57070.02000.4296.1-0.10%328
11/2941,6735.6170.0210.430.4296.21.26%231
11/28231,6695.59060.02000.36950.32%190
11/27-171,6465.51060.02000.3694.7-0.84%302
11/26141,6635.57-1160.02000.3695.5-2.15%399
11/25-221,6495.5211170.06001.0397.60.10%414
11/22-281,6715.59060.02000.3697.5-0.51%274
11/21-31,6995.69060.02000.35980.20%411
11/20611,7025.7160.0210.090.3597.81.77%1,109
11/1911,6415.49050.02000.396.10.10%275
11/18121,6405.49050.02000.3960.52%351
11/1571,6285.45-450.02000.3195.50.63%416
11/1461,6215.43390.03000.5694.9-1.15%524
11/13-411,6155.41160.02000.37961.80%876
11/12561,6565.54050.02000.394.31.07%810
11/11351,6005.36050.02000.3193.33.21%1,180
11/08-71,5655.24050.02000.3290.40.67%129
11/0721,5725.26050.02000.3289.80.45%58
11/06-91,5705.25050.02000.3289.4-0.22%69
11/0501,5795.29050.02000.3289.60.11%27
11/0401,5795.29050.02000.3289.5-0.56%46
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
12/13100-15@Limit20.0271007188990.6-2.05%371
12/1200006@Limit20.02441403081892.5-1.60%281
12/11100-16@Limit20.022240-22788940.00%262
12/1001017@Limit20.020000810940.64%193
12/09100-16@Limit20.02220081093.4-3.71%506
12/0600007@Limit20.02010-181097-0.41%138
12/0500007@Limit20.022600-5881197.4-0.41%251
12/0400007@Limit20.02290-786997.80.00%246
12/0300007@Limit20.02110087697.81.77%803
12/0200007@Limit20.020110-1187696.1-0.10%328
11/2901017@Limit20.020280-2888796.21.26%231
11/2800006@Limit20.020000915950.32%190
11/2700006@Limit20.02090-991594.7-0.84%302
11/261100-116@Limit20.024120-892495.5-2.15%399
11/2501101117@Limit20.06900993297.60.10%414
11/2200006@Limit20.027760-6992397.5-0.51%274
11/2100006@Limit20.020320-32992980.20%411
11/2001016@Limit20.020260-261,02497.81.77%1,109
11/1900005@Limit20.020520-521,05096.10.10%275
11/1800005@Limit20.0291190-1101,102960.52%351
11/15400-45@Limit20.025210-161,21295.50.63%416
11/1414039@Limit20.038260-181,22894.9-1.15%524
11/1301016@Limit20.020520-521,246961.80%876
11/1200005@Limit20.027190-121,29894.31.07%810
11/1100005@Limit20.0230031,31093.33.21%1,180
11/0800005@Limit20.02130-21,30790.40.67%129
11/0700005@Limit20.02090-91,30989.80.45%58
11/0600005@Limit20.021270-261,31889.4-0.22%69
11/0500005@Limit20.020120-121,34489.60.11%27
11/0400005@Limit20.0210011,35689.5-0.56%46
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
12/13363,281,4003,282,3009.725
12/12242,239,5002,230,1008.54-391.67
12/11353,280,8003,306,50013.36734.29
12/10222,055,1002,065,80011.4486.36
12/09736,911,6006,943,20014.43432.88
12/06161,557,1001,555,80011.59-81.25
12/05242,346,4002,342,2009.56-175
12/04434,203,8004,198,80017.48-116.28
12/03767,417,2007,426,7009.46125
12/02838,043,7008,036,00025.3-92.77
11/29343,248,1003,257,00014.72261.76
11/28312,937,9002,945,60016.32248.39
11/27282,663,7002,665,3009.2757.14
11/26565,404,7005,385,10014.04-350
11/25383,716,6003,715,2009.18-36.84
11/22636,157,5006,165,50022.99126.98
11/21848,192,9008,201,80020.44105.95
11/2021921,378,40021,444,10019.75300
11/19383,646,8003,652,30013.82144.74
11/18373,530,7003,542,20010.54310.81
11/15625,890,3005,911,60014.9343.55
11/141049,869,0009,912,70019.85420.19
11/1317716,924,60016,965,60020.21231.64
11/1216015,050,50015,063,80019.7583.13
11/1119217,994,20017,997,10016.2715.1
11/083270,400271,1002.33233.33
11/07121,075,2001,076,30020.6991.67
11/069802,500805,00013.04277.78
11/052178,900179,1007.41100
11/045448,500449,50010.87200
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章